US Patent Issued to Cochlear on Oct. 27 for "Methods and pharmaceutical formulations for modulating the properties of the blood labyrinth barrier" (Irish, German Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,554, issued on Oct. 27, was assigned to Cochlear Ltd. (Macquarie University, Australia).

"Methods and pharmaceutical formulations for modulating the properties of the blood labyrinth barrier" was invented by Daniel Smyth (Dublin) and Wolfram Frederik Dueck (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and pharmaceutical formulations are provided for modulating permeability and other properties of the blood labyrinth barrier (BLB) of the inner car. Such methods could be used in known control systems for monitoring and treating CI recipients and individuals have hearing loss-related conditions, disorders and diseases, including for ex...